InsiderClue
← All stocks

Xenon Pharmaceuticals Inc.

XENE Net selling
CIK 0001582313 #1255 in the set updated 17 Sep 2026
Bought (120 mo)
$2.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$53.66M
$3.26M on a plan · $38.28M straight out of an exercise
Sold at will
$12.11M
33 of 111 sales
Net
−$51.05M
−$9.50M against sales at will

By person

23 insiders · 217 transactions
2.6×

Ian Mortimer holds only 2.6 times base salary in stock. $2.09M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORTIMER IAN
PRESIDENT & CEO
$43.23K (2)
$24.82M (25) scheduled
−$24.78M
34,223
0.0353%
$2.09M
+545.7%
PIMSTONE SIMON N.
Director
$17.40K (1)
$14.96M (34)
−$14.95M
6,000
0.0062%
$365.86K
−97.2%
EMPFIELD JAMES R.
EVP, Drug Discovery
$24.82K (1)
$3.78M (5) scheduled
−$3.75M
10,000
0.0103%
$609.77K
—
ROBIN SHERRINGTON
EVP, Strategy & Innovation
—
$3.61M (11) scheduled
−$3.61M
8,398
0.0087%
$512.08K
+108.8%
BVF PARTNERS L P/IL entity
10% owner
$2.05M (28)
—
+$2.05M
59,464
0.0614%
$3.63M
−96.9%
AULIN SHERRY
Chief Financial Officer
—
$1.38M (3) scheduled
−$1.38M
0
0.0000%
$0.00
—
GANNON STEVEN
Director
$42.27K (1)
$1.24M (6)
−$1.20M
1,870
0.0019%
$114.03K
—
PATOU GARY
Director
$35.84K (2)
$1.17M (9) scheduled
−$1.13M
29,798
0.0308%
$1.82M
+647.6%
Svoronos Dawn
Director
$140.77K (1)
$967.50K (1)
−$826.73K
31,373
0.0324%
$1.91M
—
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
$20.17K (1)
$694.76K (5) scheduled
−$674.60K
2
<0.0001%
$121.95
+100.0%
HOLLER FRANK A
Director
—
$649.32K (7)
−$649.32K
143,653
0.1483%
$8.76M
−1.5%
DiFabio Andrea
Chief Legal Officer
—
$230.81K (2) scheduled
−$230.81K
7,301
0.0075%
$445.19K
—
Von Seggern Christopher
Chief Commercial Officer
$97.60K (1)
—
+$97.60K
4,000
0.0041%
$243.91K
—
GAROFALO ELIZABETH A.
Director
—
$95.58K (1) scheduled
−$95.58K
2,645
0.0027%
$161.28K
—
AZAB MOHAMMAD
Director
$81.14K (5)
$214.18 (1)
+$80.93K
74,225
0.0766%
$4.53M
+1,403%
Cannon Gillian
Director
—
$63.24K (1) scheduled
−$63.24K
1,455
0.0015%
$88.72K
—
Hayden Michael R
Director
$41.25K (1)
—
+$41.25K
208,282
0.2151%
$12.70M
+169.4%
SCHELLER RICHARD H
Director
$19.95K (1)
—
+$19.95K
7,000
0.0072%
$426.84K
—
WINQUIST RAYMOND
Head, Translational Research
$3.00K (1)
—
+$3.00K
1,000
0.0010%
$60.98K
—
TARNOW MICHAEL M
Director
—
—
—
77,942
0.0805%
$4.75M
+41.3%
COHEN CHARLES J.
VP, Biology
—
—
—
6,550
0.0068%
$399.40K
—
Machado Patrick
Director
—
—
—
2,645
0.0027%
$161.28K
—
Gover Justin D.
Director
—
—
—
2,645
0.0027%
$161.28K
—

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
GANNON STEVEN
11 Aug 2026
Director
Sell
10,000
$64.06
$640.55K
GANNON STEVEN
5 Jun 2025
Director
Sell
3
$30.48
$91.44
GANNON STEVEN
7 Mar 2024
Director
Sell
2,000
$46.20
$92.40K
GANNON STEVEN
7 Mar 2024
Director
Sell
5,000
$46.30
$231.51K
GANNON STEVEN
7 Mar 2024
Director
Sell
5,000
$46.25
$231.25K
GANNON STEVEN
7 Mar 2024
Director
Sell
1,000
$46.45
$46.45K
Svoronos Dawn
24 Aug 2023
Director
Sell
25,000
$38.70
$967.50K
PIMSTONE SIMON N.
30 May 2023
Director
Sell
19,000
$39.90
$758.10K
PIMSTONE SIMON N.
30 May 2023
Director
Sell
18,006
$38.63
$695.57K
KENNEY CHRISTOPHER JOHN
24 Mar 2023
Chief Medical Officer
Sell
700
$35.01
$24.51K
PATOU GARY
23 Nov 2022
Director
Sell
2,057
$34.33
$70.61K
PIMSTONE SIMON N.
16 Aug 2022
Director
Sell
20,000
$38.87
$777.40K
PIMSTONE SIMON N.
16 Aug 2022
Director
Sell
32,058
$38.29
$1.23M
PIMSTONE SIMON N.
15 Aug 2022
Director
Sell
33,942
$37.76
$1.28M
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
1,000
$39.15
$39.15K
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
47,000
$38.60
$1.81M
PIMSTONE SIMON N.
12 Aug 2022
Director
Sell
43,135
$37.91
$1.64M
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.50
$76.25K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.55
$76.38K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.20
$75.50K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$30.10
$75.25K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,500
$3.80
$9.50K
PIMSTONE SIMON N.
8 Mar 2022
Director
Sell
2,051
$30.60
$62.76K
PIMSTONE SIMON N.
15 Nov 2021
Director
Sell
17,557
$31.33
$550.06K
PIMSTONE SIMON N.
1 Jun 2020
CEO
Sell
3,000
$14.43
$43.29K
PIMSTONE SIMON N.
29 May 2020
CEO
Sell
5,000
$13.99
$69.95K
HOLLER FRANK A
20 Sep 2019
Director
Sell
5,206
$9.39
$48.88K
PIMSTONE SIMON N.
20 Sep 2019
CEO
Sell
10,395
$9.51
$98.86K
HOLLER FRANK A
19 Sep 2019
Director
Sell
7,600
$9.27
$70.45K
HOLLER FRANK A
18 Sep 2019
Director
Sell
4,368
$9.28
$40.54K
HOLLER FRANK A
17 Sep 2019
Director
Sell
5,069
$9.32
$47.24K
AZAB MOHAMMAD
13 Sep 2019
Director
Sell
23
$9.31
$214.18
HOLLER FRANK A
15 Dec 2016
Director
Sell
30,000
$7.85
$235.50K
Show all 217 transactions →

What was left out

Form 4 filings counted 256
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 64
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 4,418,692
Sales filed before the plan box existed 23
History held since 27 Sep 2016